|

- 积分
- 3
- 威望
- 3
- 包包
- 20
|
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸
7 A0 {5 W* S! u _/ S2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
3 x0 W$ |7 v% t8 ]3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷
5 h* v D& e; ?9 R- ]4 c1 m5-Aza:5-azacytidine,5-氮(杂)胞苷
! L. c( ^0 u4 a: G, Y0 S( Na2-PI:a2-antiplasmin, a2-纤溶酶原抑制物; c* M# p: d8 @: u
AA:aplastic anemia,再生障碍性贫血$ S5 V$ a! ~3 j7 T" `% a( e: Z
AAV:adeno-associated virus,腺病毒相关病毒
/ M) z8 C; E" D1 E0 ] A- wAb:antibody,抗体, x' S2 y- q1 C0 \- t% D8 Y3 L
ABC:avidin-biiotin complex method, 亲和素生物素复合物法2 r! t1 W# k, J! S3 m; C' F
ABMT:autologous bone marrow transplant,自体骨髓移植! ~0 S1 Q! K$ ^( p2 P1 F
Ac:accessory cell,辅佐细胞
# I3 S1 W8 p3 p/ o$ a3 |ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖2 F% L9 ?, I' h7 i# A( N4 z
ACP:acid phosphatase,酸性磷酸梅6 O4 l9 |2 m# e5 B9 y; N
ACTD:actinomycin D,放线菌素D
- l9 h) I) a1 r$ Y" U3 c4 GAcute:急性的 4 Q0 R2 k* z1 k, ~% L' c! [! Q) @1 o
ACV:cyclovir,阿昔洛韦
2 O8 u) F! q/ K9 ]1 O! q, X: _Ad:adenovirus,腺病毒
: C# a: ^* n9 E- Y6 j7 a: rAD:antigen determinant,抗原决定簇
/ {2 D! L0 U1 A1 uADA:adenosine deaminase,腺苷脱氨酶
( ~1 o! T9 ?, gADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性+ M2 c( G+ k+ n) e0 X# d
Adjuvant therapy:辅助治疗
: f! Y: B' d4 K2 u6 R/ ZAEL:acute erythrocytic leukemia,急性红白血病 f/ [" Z+ _/ I. n# a: [( y6 s8 }
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病. h: a( E. Q; p* X2 ^3 O! _
AFP:alpha fetoprotein,甲胎蛋白
: g/ R: w* T" P2 nAg:antigen,抗原8 n) @4 [. q) |* i6 t% H2 j1 }7 r' a7 a
aGVHD:acute graft versus host disease,急性移植物抗宿主病
! g% S% s/ r# T* d: d' K1 T+ qAid:anti-idiotype antibody,抗独特型抗体
/ c' G; `' o. }) Y4 p& b$ J9 ^4 HAidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征
. v& Y' ?4 \) w/ o$ s; ^( B! bAIF:apoptosis-inducing factor,凋亡诱导因子$ r$ }$ b" L' G+ X; @" i
AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血# i. s3 U ?3 T7 x
AL:acute leukemia, 急性白血病3 F z S6 j6 Z5 q; D
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤$ o, I* o% A) g# b# |) P( S Q+ O: Q; w% [
ALG:antilymphocyte globulin, 抗淋巴细胞球蛋白$ }; B+ |( l& s( n' ]3 x; q
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
/ P0 V9 [6 I& O/ S' ]# vALL:acute lymphocytic leukemia,急性淋巴细胞白血病
s1 H7 S$ V" I2 K/ u$ q U4 LAllo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植3 F/ p( Q" K0 c( h% k
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
6 ~, z5 G0 t* l z/ C. ]7 ?! QAllogeneic:异基因的 0 p3 ~! l& c9 H
Allograft:异体移植物
& R1 ~$ T9 T4 C& Y. d: XAlopecia:脱发
) Y$ p8 z9 Q4 TALP(AKP):Alkaline phosphatase,碱性磷酸酶% [5 C! o9 T7 D# J
AM:adhesion molecule,粘附分子/ Y* y1 n" I! ?4 P( M! }) d2 `
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
' g: [7 T+ E4 [AML:acute myeloid leukemia,急性髓性白血病
1 q$ H6 S5 `8 k4 ]$ [$ n( [, uAMM:agnogenic myeloid metaplasia,特发性髓外化生$ X' [3 F( ?7 i6 ~2 i E2 [
ANA:antinuclear antibody,抗核抗体
5 K5 ^2 ~1 X1 Q! r2 W* Y/ @3 tAna-LL:anaplastic large cell lymphoma,大细胞淋巴瘤8 Y6 i5 M* f( K! _8 I1 R: b y' S
Anaphylaxis:过敏症
9 \ J% Q& J9 B4 G: B; z* f) j
5 L- k( r6 w$ e" WANC:absolute neutrophil count,中性粒细胞绝对值
& @" P1 ~. D. g8 ~Anemia:贫血9 b5 U* U& I& `
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
! q5 ]. }2 a0 ~2 U( lAntibiotic:抗生素;抗生的
& M, R9 ^" X' O- h8 ~- C3 w# ?Antiemetic:止吐剂,止吐药
( ^: {$ V3 \4 I/ z: ?0 Gantineoplastic drugs:抗肿瘤药物
8 s4 F1 [# b# ~' W* J; E3 FAntisense:反义引物
; `0 Q( Y' F1 ?4 z* i6 z+ n" vAPBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植
4 X! S0 l# i' Y2 {, F* {% g' rAPC:antigen processing cell,抗原呈递细胞( Z$ E( a$ s+ U5 D* S" b
Apheresis:血浆分离置换法,血液成分部分清除 ; O; j2 r! x8 t! f9 W+ M
APL:acute promyelocytic leukemia,急性早幼粒细胞白血病
& ?1 g1 ]: `7 N3 zAplasia:发育不良,成形不完全 - X0 {; U& J! Y- F' R0 l' p) b. Q
Apoptosis:凋亡$ Q/ {7 t, x) D- k) @! m
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
4 L& D' p7 I2 J: I* n: KARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病
. {( R, [3 \' l* i! H& G+ a& PAscites:腹水
3 e! C9 c D1 @( y8 bASCT:autologous stem cell transplantation,自体干细胞移植
# F8 N3 B, j, [7 v7 L; j1 |% i% BAspergillus:曲霉属8 U6 ~: ]2 }% [9 i9 _9 P
ASS:anterior superior spine,髂前上棘# I3 I1 G8 [4 f' }- t1 E
AT1257:nitrocaphane,消瘤芥+ d% D5 S- b) f5 l6 {& P
ATG:antithymocyte globulin,抗胸腺细胞球蛋白
+ e* v" Q" l1 J [. N: r3 ~ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤6 i# y& D1 ?! j- m8 T+ C# {2 k
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
6 Q& u2 r! E* Y! |ATRA:all-transretinoic acid,全反式维甲酸
W- \+ }2 o4 L7 ]& qAUL:acute undifferentiated cell leukemia,急性未分化细胞白血病9 p1 S N: e/ m
AuSCT: autologous stem cell transplantation,自体造血干细胞移植( ?8 J, U* F$ a) r! N2 ]6 D
Autologous:自体的
! J" n# g8 }- z' uAutograft:自体移植物 1 d9 F% E L) `1 {% l0 q, @+ @
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
0 E M0 i' w* v8 |β2-MG:β2-microglobulin,β2-微球蛋白2 a. G4 } d6 {. x" B G) o) Y
Back-up:备份7 q! S O. b& }; l
BCNU:Carmustine,卡氮芥,卡莫司汀
0 \( a1 c8 L4 @BCR:breakpoint cluster region,断裂点丛集区
8 t. c- k% {9 t1 j) SBFU-E: burst-forming unit-erythroid,早期红系集落生成细胞9 i8 W; P ?$ Y0 R
Biopsy:活检
! ]3 D) Q1 q4 t: y" FBlast cell:原始血细胞,母细胞
- o6 [+ Y1 ~" F2 |9 f5 rBlast-CFC:blast colony forming cell,原始细胞集落形成细胞 w% T* o/ f7 J
Blast crisis:原始细胞危象 6 ~$ R8 A* p9 L9 g6 e! M4 u: i
Bm:memory B lymphocyte,记忆B淋巴细胞% R3 B7 K; E! w. m. {# N
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病) F$ M( {' g, v
BMT:bone marrow transplantation,骨髓移植
# s# L& {, o7 R0 r. ^$ ]Bone marrow biopsy:骨髓活检& v) C# v( \9 C5 ]6 k8 K1 ~: Y1 X
Bone marrow puncture:骨髓穿刺
' W2 D" z2 |" P/ g" OBone marrow smear:骨髓穿刺涂片
/ Z% F/ q: x7 e3 Y0 `6 KBRM:biological response modifier,生物应答调节剂
9 x5 r& k+ C0 f1 H: R. X4 OBu:busulfan,白消安,马利兰 ! x, h4 ~, {- A
Buffer:缓冲,缓冲剂,缓冲液3 e7 L0 @+ w& L2 @) Y6 A) D- X
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原 B1 T4 F& D9 _, F, g: V' T
CAM:cell adhesion molecule,细胞粘附分子
: Y9 Z( f4 ]0 s \! ACandida:念珠菌属,假丝酵母属
/ r: a# T' ^* f2 N+ V( {Catheter:导管
" [6 D9 I% G& a. i$ i4 BCB:cord blood,脐带血
6 r6 [# l% @1 q8 p2 RCB1348:chlorambucil:苯丁酸氮芥% b& m9 l8 a1 |9 A7 k3 [
CBC:complete blood count,全血细胞计数
4 d2 i* F. L; l7 X8 v) Q% I# u7 _CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
9 ~! j1 K# a) m9 c5 n1 U# wCBSCT:cord blood stem cell transplantation,脐血干细胞移植
/ w8 M" [6 k. `CCI:corrected count increment,校正增值计数
2 ~( b, |" L1 E' \$ ]5 t/ CCCNSA:cell cycle non-specific agents,细胞周期非特异性药物
7 |1 Z9 o7 ~; a$ |- y9 YCCNU:lomustine,洛莫司汀,环己亚硝脲
9 Z3 W: C$ ]5 ~" \% t6 }% I1 [CCR:continuous complete remission,持续完全缓解
2 z5 x+ [$ N+ jCCSA:cell cycle specific agents,细胞周期特异性药物
) Q4 a* t/ ?! n. v0 u& k; iCD:Castleman's disease,Castleman病7 k( X6 B, o" m7 B5 y: ^
CD:cluster of differentiation,分化群- \% F s2 @3 w6 K& f
CD3AK:CD3 activated killer,CD3激活的杀伤细胞
! p4 I* n1 i! Y, ~9 b% ?CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
9 I; n6 h/ ^0 L( u9 @% HCEA:carcinoembryonic antigen,癌胚抗原
x; H0 {3 c/ J0 @5 E. R# bCEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
, Z' B( f% ?0 _5 sCentral line:中心静脉导管,见central venous catheter.
1 r" z8 q" U2 {Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter
3 j- J q# W0 H' fCentrifugation:离心
. N7 ]% z7 t/ u" WCFC:colony-forming cell,克隆形成细胞
; [2 g7 g4 f. k* c" f& d0 f+ o9 d8 m: PCFU:colony-forming unit,集落形成单位
" X$ v5 E& o+ j, ZCFU-Blast:colony-forming unit-Blast,原始集落生成细胞
( V$ R- \* r$ c) }) s% ?, eCFU-E:colony-forming unit-erythroid,红系集落生成细胞" \: U! V7 G* k) _& p7 K2 m
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞! ^0 |. \7 t2 g/ z2 L
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞# u6 d7 z5 w9 i: G; l; c/ F% l
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
6 K3 r4 P$ {8 wCFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞- C# `/ n$ c0 `; V$ d
CGD:chronic granulomatous disease,慢性肉芽肿病
) B* ]3 b0 j; s- j' n& vCGP:circulating granulocyte pool,循环粒细胞池
/ B& e; B% ]: R# N6 W# ncGVHD:chronic graft versus host disease,慢性移植物抗宿主病3 }4 D; A+ X' O
Chemo-responsive:化疗敏感的
+ v3 y/ b) y0 n- v$ |" SChemotherapy:化学疗法
& x9 e8 [" F& z( @; yChronic慢性的 " ?3 z- X# _2 q$ G0 o6 q; W# C
C.I.:continuous infusion,持续静脉点滴6 l. z7 Z& i" H* H
CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
, o( {+ t& F5 f5 m! G, A* w+ }! jCliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
( Z: O) x- m7 z* o( v7 C# B) D6 wCLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病/ ?/ b; ^8 B+ W# e) e$ U
CML:chronic myelogenous leukemia,慢性粒细胞白血病3 L- |2 O/ M- E0 ^/ K
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
' v& h' R% Q1 ZCML-BP:CML-blastic phase,慢性粒细胞白血病急变期' i* E* H! H' m' G
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
" _' R o2 j' K, lCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病/ m; p( T7 D% Y6 ?3 P* S/ O7 g
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病+ B2 y. [; N! v/ v
CMV:cytomegalovirus,巨细胞病毒
. F" o6 `7 [. E, s+ t! c; \8 QCNR:cytokine negative response cell,细胞因子不反应细胞- `/ |0 Q$ O) y* h4 d
CNS:central nervous system,中枢神经系统5 |7 V" {0 q3 z9 i
CNSL:central nervous system leukemia,中枢神经系统白血病
0 t2 b; c# r: N- z0 YCollection: 采集
! h: e% \' a% P- e% R. O, pColony stimulating factor:集落刺激因子
/ Q* N* u8 Z( S) mc-onc:cellular oncogene,细胞癌基因' p6 w0 k: S* X' i; V( C! @! X) b
Conditioning:预处理
% |# {! ]- u+ g. a" xConjunctivitis:结膜炎
" l* v. D" _' fConvalescence:恢复,恢复期* Y* V4 d0 P+ |7 Z8 O
CP:cancer procoagulant,癌性促凝物质
# ^" r+ r; H7 K7 vCPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖1 a8 M" A, {7 ~6 y, @& H
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
8 x! s. ~$ n5 O k& `Cpmax:peak concentration,峰浓度4 p6 W, Y8 s% s" Q* { C. w2 ^# L9 {" m
CPT:camptothecine,喜树碱 k" V$ S! H. S) H+ F$ l
CR:complete remission,完全缓解
6 T+ e0 i- b- G! h( f3 E/ S/ sCRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
+ `: Q& |0 D/ ]0 I( I4 i6 x5 S' n9 fCRP:C reaction protein,丙反应蛋白 ! _/ [2 z" T, F* v4 j% k8 ~1 O; H1 M3 m
CRR:complete remission rate,完全缓解率' Q) A$ f# f, U6 a' M0 v- A
Cryopreservation:冷冻保存,深低温保藏
5 t- g ~1 r6 j' yCSF:colony stimulating factor,集落刺激因子
# J( A) j, G7 v9 v+ GCSF:cerebrospinal fluid,脑脊液
( z' Y) u# y8 q U t+ Q: WCTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
; d$ k6 i/ g9 YCTCL:central T cell lymphoma,中枢T细胞淋巴瘤
3 f" W' I- {3 N; j! Q6 hCTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞3 E3 U/ u( S9 Y" _* W! z
Cyclin:周期素
; Z& {8 v; ~* X' M% p4 x0 z# G6 iCytomegalovirus:巨细胞病毒
4 U4 Z8 t5 p3 [DC:dendric cell,树突细胞, l6 ]; X7 r) V
D-D:D dimer,D-二聚体3 _+ b6 O; v5 d/ N4 g( [0 f
Del:deletion,缺失/ e+ \- N& _4 {8 z
Dermatitis:皮炎
P4 K# U v( B; n+ j1 ODe nova AML:非继发性急性髓性白血病 ; D$ f+ \$ i! A1 \
DFS:disease free survival,无病生存期! F$ O! x: B$ r+ @
DI:DNA index,DNA 指数, `( w% v+ _4 u( W
DIC:disseminated intravascular coagulation,播散性血管内凝血
$ u: `3 ?( |6 Y' _. oDilution:稀释
6 q. Q3 ]! [! n) b# W) s6 X. ADL:discordant lymphoma,混杂型淋巴瘤" |: z7 @0 x. ]5 B! J3 n
Donor:供者
) A6 x+ O- S5 E( P$ bDysplasia:发育不良,发育异常 # X5 i4 V; I7 M
EBV:Epstein-Barr virus,EB病毒
5 ~$ Z1 d) @1 N8 n% l* [ECM:extracellular matrix,细胞外基质
, D, s, M! o- F- i" o- D- z3 [" I-ectomy:(后缀)(外科)切除,除去,去掉
; v/ I$ w+ K6 f0 L8 zEdema:水肿 0 P! l% u( s9 |
EGF:epithelial growth factor,表皮生长因子' f* k( l! R7 k7 h$ r
-emia:(后缀)血液疾病
7 m3 m Z9 p AEncephalopathy:脑病
! n b4 `9 M. f) Q( i8 ?2 CEncode: 编码* Q0 d+ l( a7 z
Engraftment:移植物植入 2 V& |( L# B1 @2 J1 X8 p3 A
Enrich:富集
: ?/ M3 \9 D8 I9 ZEnzyme:酶 7 M; G# {9 x- m
Eosinophil:嗜酸性粒细胞
$ V8 d K3 B J2 z; qEPO:erythropoietin,促红素,红细胞生成素; w0 `+ `7 |8 e
ETT:essential thrombocythemia,原发性血小板增多症
) l) i. \& \' }/ }% |' REx vivo:体外 : N+ ]) I; r6 j
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统
( ?4 V0 K3 s4 B+ jFCM:flow cytometry,流式细胞分析技术
# P' c& n) \0 F! f& TFDC:follicular dendritic cells,滤泡树突状细胞
5 c/ b+ f! ^4 [/ a& ]% X7 nFDGF:fibroblast derived growth factor,成纤维细胞源生长因子
6 Q4 d/ @. I+ m+ f% ^1 yFebrile:发热的
2 l4 D* p3 C8 O" n" t; }# }FFP:fresh frozen plasma,新鲜冰冻血浆4 ] O6 N+ S/ K8 y4 [1 i
FGF:fibroblast growth factor,成纤维细胞生长因子5 Z. |" q: P2 D- D6 s& j7 Q: l
FHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症! B& ^ G& d. n3 P, c
FISH:fluorescence in situ hybridization,荧光原位杂交! L: @3 U" [; q' g: o H
FMF:familial Mediteranean fever,家族性地中海热
2 @/ G! {# z* N- c; gFoley catheter:弗利氏导尿管,气囊导尿管 6 s; a3 W' _4 a0 N F: {
FrTBI:fractional total body irradiation,分次全身照射
) R' D5 g2 a' ?+ n# E" G$ U# [' fFSRC: 胎羊体内增殖的人造血干细胞$ u' v0 n, b; W: H) |, U6 c3 d7 z
Fungus:真菌
( H( u- G" h* _; Y" i5 RFungi: Fungus复数形式& S; c* r- ~: Q7 D! X3 z, }, L! y
G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
6 K/ u" R+ b- \2 V6 @Gastritis:胃炎 9 ]; `( B& C+ k9 h% B9 Q
Gastrointestinal:胃肠道的
: V3 c/ b. c7 ~* LG-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
I, y8 ^" y6 {! r2 h* rG-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
: l3 ~2 {5 u, P% [- ^# }GCV:cytomegalovirus,巨细胞病毒
) l& d4 P1 D6 o2 r1 [GCV:ganciclovir,更昔洛韦! i( t4 U7 b; Q2 W1 y
GI:gastrointestinal,胃肠道的6 T6 [ g9 Q& i& g$ I4 f; W
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子
( ^" p% O* B/ j7 _& Z8 zGM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
9 j1 h7 h6 V! e1 LGraft rejection:移植排斥(反应) / Y g7 i. {& }" {
Graft-versus-host disease:移植物抗宿主病
+ @5 k: I/ Q4 O0 ]0 uGranulocyte:粒细胞
! T* }% x+ d, {( G6 P/ [Growth factor:生长因子 9 t K3 n- n! z I: E4 D2 s
GTR:granulocyte turnover rate,粒细胞转换率
W. N* i3 |+ Q% n! l3 U$ A0 ^GVHD:graft-versus-host disease,移植物抗宿主病
* O0 k4 N1 H" I6 a, V" [" i5 c! x cGVHR: graft-versus-host reaction,移植物抗宿主反应5 ?# S- ]/ c; r2 U, C& y
GVL:graft-versus-leukemia,移植物抗白血病. G' U& h! J/ y7 d* I2 d6 \$ B: x
GVT:graft-versus-tumor,移植物抗肿瘤
% M* J @! H% [* u4 w# t% n. AHaploidentical: 半相和的
& @/ ~( M4 _- G( I) CHarvest: 收集,采集
' z! t7 u$ X& s3 w/ `HC:hemorrhagic cystitis,出血性膀胱炎
0 l6 h. Q# ]7 d' lHCL:hairy cell leukemia,毛细胞白血病4 d6 t0 H8 o: f& U0 f( `( Q: j& \" }
HD:Hodgkin's disease,霍奇金病; n7 V9 d. T, @1 b+ J- N0 V8 l4 g0 z
HD:high dose,大剂量7 R5 b8 t( f9 ]* }( N' K
Hematocrit:红细胞压积
( T! b' r# f4 m8 E% Q" \5 PHematology:血液学
# S7 S" j& u: U& R% Q" x8 oHematopoiesis:造血作用,生血作用( H4 T/ Z3 K8 u$ b& u
Hematopoietic system:造血系统6 ?6 w$ m% Q$ r$ l J
Hemoglobin:血色素,血红蛋白 ! a' }' D" X$ m$ P( R0 s1 E5 d. O
Hemorrhage:出血
( E) a( O e, P% SHemorrhagic cystitis:出血性膀胱炎 8 v% n& n4 D9 t( x+ N, W
Hepat - :(前缀)肝的
1 `9 w3 e1 l G8 qHepatitis:肝炎 6 [/ |. B/ J9 U, b- a$ ] t' U
HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征0 Y. F0 E3 ]) d/ A4 V
HGF:hematopoietic growth factor,造血生长因子1 @. ]$ B# Q' h
HHV:human herpus virus,人疱疹病毒
1 y8 Q7 j, o( Q" |Hickman catheter:Hichman导管,中心静脉插管
( y9 l) c4 F3 |5 E, WHIV:human immune deficiency virus,人免疫缺陷病毒$ {5 E1 Z& K) v8 `4 O7 O3 @
HLA:human leukocyte antigen,人类白细胞抗原 $ g9 R* ^/ ]. b. n& H" f5 o
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症; O2 t. ]( J+ _
HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
% ^$ U1 G# s# R2 e& P* a. h" XHomogenic transplantation:同基因移植6 o$ H1 Y3 v% u) p( l# Q
Homozygote:纯合子5 p" L3 t' Q+ t8 F4 t- }, @4 d( F( |# ^
HPC:hematopoietic progenitor cell,造血祖细胞, \5 L3 P; G( L3 x8 ]% `8 w) Q
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位
7 |/ i& x0 t7 w8 V0 CHR-ALL:high risk ALL,高危型急性淋巴细胞白血病
# d6 ^; S6 T8 B1 Y/ Q. I# ^& U% OHSC:Hand-Schuller-Christian disease,韩-薛-柯病% f/ ~( B6 u @6 K
HSC:hematopoietic stem cell,造血干细胞
* o# g8 {" G" K; X; U0 S5 @HSR:homogenously staining region,均染色区; t5 b% f4 i) W+ E9 q
HSV:herpes simplex virus,单纯疱疹病毒9 R, t: H0 a7 e. J+ i, c7 p
HTC: typing cell,纯合子分型细胞; [# ~7 r4 x* K
HTLV:human T cell leukemia virus,人类T细胞白血病病毒/ [4 e1 G4 @" H l' z, N! H
HVOD:hepatic venous occlusive disease,肝静脉闭塞病
, P8 x9 v* C d9 U% F& }3 l, W; ^Hyper- :(前缀)高,超,(过)多
: Y7 j6 E$ E0 G& w+ [0 PHyperalimentation:高营养支持,静脉高营养
1 U) c" T6 e8 c( \Hyperpigmentation:色素沉着过度
& A. d; m: P* m0 HHypertension:高血压
2 {; C- y+ k' ~! h5 {& A" w( p) E% O% yHypo- :(前缀)(过)低,少于' h" _# y# E/ k/ t! I% _6 q
Hypotension:低血压
9 j& m7 m! y* F, UIAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
. @# Z1 H5 \6 A7 Fid:medium dose,中剂量
! P" R5 l8 B" O9 Z4 O: [& r. z7 pid:initial dose,初始剂量. h, ?" X8 V2 U" v% b) N& G8 K
IF:involved field,累及野
4 E3 _$ h& e7 f) q" n9 g3 AIFN:interferon,干扰素
9 R6 m5 X( ^/ ~' N# zIg:immunoglobulin,免疫球蛋白 1 i& |$ ?$ Y w
IGFs: insulin-like growth factor,胰岛素样生长因子
" M% Z0 Q6 z* o# l8 YIgH:immunoglobulin heavy chain,免疫球蛋白重链
3 n9 m2 [3 _9 M3 \IL:interleukin,白细胞介素3 G1 t9 i2 y4 r+ q% t2 T
Iliac crest:髂嵴 ( n% I K* [$ R& o/ f1 G) s
I.M.:intramuscular,肌肉注射
$ i$ d4 B; H- L- X6 r* yImmune system:免疫系统
* s9 N- }- |3 k7 M: aImmunocompromised:免疫受损的 $ ?3 B2 e% |9 x' w3 u' H
Immunoglobulin:免疫球蛋白 ' n1 h2 W8 ^) i+ b N& A) n
Immunological tolerance:免疫耐受4 A! [( P* q' W7 ^0 {( p5 m/ t' h
Immunosuppression:免疫抑制 : \# l+ i# X. `# x% O& G* q
Incubation:孵育4 U% I5 t/ z4 U6 b D! E2 [
informed-consent:知情同意
* p4 [" {% V* kIntravenous:静脉内的* E/ @$ I& f9 S' {8 R' J
inv: inversion,倒位
; h0 W1 O) r) @in vitro: 体外,离体$ r' ]+ A5 \( a* ~
in vivo: 体内
4 s& j% M6 Z `- e0 e# aIP:interstitial pneumonia,间质性肺炎! [% Y7 }+ A' C) b* L
Isolation: 分离
) J# K# H+ L3 s v T, H* W( xI.T.:intrathecal injection,鞘内注射6 a3 S/ X1 S& Z( C
-itis:(后缀)炎症
! R+ T0 i* O- |% z+ W4 YITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
4 B/ n# i3 G' f5 J" g, X9 I' NJaundice:黄疸
. J/ }% { L' k8 S; qKPS:Karnofsky score, Karnofsky评分
1 h! |, A$ ~7 d8 `' q7 K1 z9 ^LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
2 v0 x. J( i6 L1 X3 ALaminar air flow unit:层流间
, _$ Z2 Q: f2 E7 ]5 q7 j0 Q2 ZLCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症- d0 _* T9 M _" K" i, ]
LD:lymphocyte depletion,淋巴细胞消减型
( ~. s, ]: z" i# a7 v1 rLD:low dose,小剂量4 {. v0 P, [; H% }
LDH:lactate dehydrogenase,乳酸脱氢酶3 `! P3 e4 y; r4 @5 Z3 m3 Y
Leukapheresis: 白细胞采集物
$ A) i) d6 d3 B4 r, mLeukemia:白血病 - l1 I8 u" S! h
Leukocyte:白细胞0 Z% ?* N- e/ U) U& y( r9 v
Leukopenia: 白细胞减少症% E- k) h/ Q; r% [- v, e
LFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 7 P" s, N9 G, y, T* X
LFS:leukemia free survival,无白血病存活期
' Z1 o9 H' [9 z cLGL:low grade lymphoma,低度恶性淋巴瘤
* F" s3 }' u' k) @/ w6 i9 ILHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
& r% z t# O# k' v V' CLI:labeling index,标记指数
3 Q; K6 Y8 A, yLIF:leukemia inhibition factor,白血病抑制因子
. ^0 D, n1 \5 x, `0 w, I& uLineage:系6 M- T% M; Q$ N" e6 }9 E% }% {7 \
LOH:loss of heterozygosity,杂合性丢失" G# M( R# r7 ?" h
LP:lymphocyte predominance,淋巴细胞为主型. ?$ d0 E0 B/ j
LRP:lung resistance related protein,肺抗性相关蛋白
# J7 @, i# l* e7 ]6 Q+ LLTB:life-threatening bleeding,致命性出血5 w- v/ n1 ]9 S$ w: ^1 k0 i' \
LTC-IC:long-term culture-initiating cell,长期培养起始细胞
0 r6 [2 k) p! f2 O; ]LTR:long terminal repeat:长末端重复序列
/ M4 \ d! v4 A# vLVL:large volume leukapheresis,大容量白细胞单采$ E0 _ \* i/ o+ P
Lymphocyte: 淋巴细胞
0 k7 Z4 I' {- J; u; v- l9 _Macrophage:巨噬细胞
( d4 w! \: A# d& S0 D* c8 I0 yMACS:magnetic activated cell sorting,磁性活化细胞分选 v/ U9 o) u. m) }/ W
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
. z( L8 _! n3 l* x* _, F' I* X9 OMalabsorption:吸收障碍$ Y* B h( |8 M, @- a' u, X; O
MALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷: r( m% u$ c' F) m- a1 ]
Matching:配型
0 ^' P8 A9 D& h: s, o5 i" \3 @MBDI:marrow blast decline index骨髓原始细胞减少指数5 c5 t2 p, U1 k& e0 B1 g
MC:mixed cellularity,混合细胞型: @/ A2 H. x/ g( c' `1 u. M h1 h
McAb:monoclonal antibody,单克隆抗体; P4 N- f" s( k1 x
mCR: median complete remission,中位完全缓解 # U, Q. Z$ F( g* Q: G1 N a
MDR:multiple drug resistance,多药耐药6 d# d/ o- i( Y& m; @! J( X# L% i
MDS:myelodysplastic syndrome,骨髓增生异常综合征
1 R! ?9 Y$ W* i/ c0 {& e5 MMegakaryocyte:巨核细胞$ T. \6 Z- L+ G
Metabolite:代谢物
4 G [6 H* p {9 \3 K' \Metastatic:转移的 . ]% d; q( u5 N2 ~. c3 y
MF:myelofibrosis,骨髓纤维化
0 h5 U+ V1 T: F- j# wMF:mycosis fungoides,蕈样霉菌病
M6 [+ O: _8 K9 Q+ I2 WMGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
( L' }0 L6 O0 i6 X' I0 d( xMGP:marginal granulocyte pool,边缘粒细胞池
! W! a$ N8 M& LMGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症9 K- w! S2 B8 n0 g% ^ X6 c3 ]* H
MH:malignant histocytosis,恶性组织细胞增生症# q/ }# l2 h% I6 Q
MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
. O+ S. m4 L& N Y e# p0 b3 sMHC:major histocompatibility complex,主要组织相容性抗原复合体
: r+ _% D7 b0 J. a8 [4 _# UMLC:mixed lymphocyte culture,混合淋巴细胞培养
- x9 w- @, J6 v8 iMLL:mixed lineage leukemia,混合系白血病
- a7 p P3 e( y* I' VMM:multiple myeloma,多发性骨髓瘤
* Q3 W4 A6 n0 eMNC:mononuclear cells,单个核细胞
* s$ T1 q6 n+ s9 N ~7 n* k; EMobilization:动员" [9 K( ~! n; Q- F, B3 J
Monoclonal antibody:单克隆抗体
# e" u& r$ g- ~! y2 d7 k0 F" RMonocyte:单核细胞
6 u, |; `( [( q9 h% |Monozygotic:单合子的
% @: H; A3 c1 m" D. oMorbidity:发病率 : y4 U" P3 w6 i; c
MPD:myeloproliferative disease, 骨髓增殖性疾病
3 i* o7 L( \8 M6 kMPO:myeloperoxidase,髓过氧化物酶
/ U, ?6 c" V1 |) F- R: H0 g- qMRD:minimal residual disease,微小残留病变 & X3 t6 q7 i# b+ X/ j+ [
MRP:multidrug resistance-associated protein,多药耐药相关蛋白" G: O3 `. U3 \5 Z( [" r0 K
Mucositis:粘膜炎 9 ?7 v, P7 L4 r, f l3 l) ]
MUD:matched unrelated donor,非血缘关系配型相合供体
7 R8 I; Y0 a% J1 c/ |: MNAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶
" H9 o4 W6 s& @4 x0 [NB:neuroblastoma,神经母细胞瘤
: g4 |0 G, u5 A# KNBM:normal bone marrow,正常骨髓
% J& v( q( w XNegative selection:阴性选择& X4 \% f, n1 W( N
Neuro- :(前缀)神经的- z6 n7 \( R$ k+ F' l) B, W
Neutropenia:中性粒细胞减少症 0 z* J. q, b6 y2 ~6 A9 F
Neutrophil:中性粒细胞
) F! b6 |2 _6 C, {4 K+ wNG:neutrophil granulocyte,中性粒细胞
- m" R; r, v1 k' h: R3 a" T. t$ ~NGF:nerve growth factor, 神经生长因子' r! H% o1 y; v! P k, y9 n
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
0 H6 h. S( K& h- i- |NK: nature killer cell,自然杀伤细胞
2 Y) U: v# w; g( J7 SNonmyeloablative transplantation: 非清髓性移植
& }6 g7 T, x1 Z. CNPO:不能进食 2 B5 k. J) {$ Q. a5 t
NS:nodular sclerosis,结节硬化型 ) o, Y( h% A0 n) N9 c
Oncology:肿瘤学
8 _3 U/ P2 u& J4 W# v$ v( eOto- :(前缀)耳的
4 U: \) [5 Y0 v9 ]0 l1 ZPA:plasminogen activator,纤溶酶原激活物
! x2 ?# z' o, j5 G7 lPacked red blood cells: 压积红细胞
& P, L+ i/ v2 ~: D. D( oPAE:post antibiotic effects,抗生素后续作用8 A6 \1 g6 ?& J S9 X5 R
PAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
+ I e' S5 Q. i; Y8 p8 U4 wPalliative:减轻的,缓解的 , C) T# C1 m) [) `/ T
palliative care unit (PCU):终末期病房,临终关怀病房
! l& X: X! u, d9 y. ^7 E+ NPancytopenia:全血细胞减少症 : Z4 G; ^1 R7 a0 v/ Q8 l8 R
-pathy:(后缀)病
# [" ~/ I2 a5 q- `8 PPB:peripheral blood, 外周血
" a3 N7 z, X& b+ zPBL:peripheral blood lymphocyte,外周血淋巴细胞
0 [( f. a- G. D+ h* q% V& OPBPC:peripheral blood progenitor cell,外周血祖细胞
+ E1 G) ?+ [3 p7 `PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植
* L) I' D- `: D$ U# OPCA:procoagulant activity,促凝活性物质
% x" v) y$ g1 [PCD:programmed cell death,细胞程序化死亡% k# c; Y7 b8 ]& F% j
PCL:plasma cell leukemia,浆细胞白血病
9 C) q% t& ~, O. M; P' O lPCLI:plasma cell label index,浆细胞标记指数
* U/ q9 \9 T7 ^: {. oPCR:polymerase chain reaction, 多聚酶链反应
% f! F8 P/ }; ]PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
2 Z' X( j0 p" ^/ s7 n3 v3 R7 qPCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交
( c4 Y+ l. U$ _# n: H' X' R# [PDD:percentage depth dosage,百分深度剂量
+ X( |. U- Z- K: l+ n6 v+ cPDGF:platelet derived growth factor,血小板衍生生长因子* Y. n) `9 V( |
PDR:primary drug resistance,原药耐药& m9 j3 |0 S7 i
PE:plasma exchange,血浆置换
~9 b9 Y/ f l- }3 M' T-penia:(后缀)缺乏,不足
* @$ P- Y1 i6 n" |Peripheral neuropathy:周围神经病变
* J' Y0 w) V N! G/ u; VPetechiae:瘀点,瘀斑 * i0 `- h5 [, T" {9 n8 g7 N8 M
Pfu: plaque forming unit,空斑形成单位
9 D8 h' @! M( l _7 HPHA:phytahematoagglutinin,植物血凝素
4 e( A) Y" A' h+ U& h8 u3 YPhlebitis:静脉炎
2 J/ Z9 o1 O+ v5 m/ yPHSC:pluripotential hematopoietic stem cell,多能造血干细胞
* }, J2 j$ i. z6 J. g-plasia:(后缀)发展,形成
! l! o# @* b5 U: J4 t7 o& mPlasma:血浆
+ h" _$ _! t) PPlasma cell: 浆细胞 6 f+ T3 Y* T% J/ H( D/ _
Platelet:血小板
7 _# d* R! E, a. KPLG:plasminogen,纤溶酶原- i- l% H) S4 J F% ]- L" e7 v
PLL:prolymphocytic leukemia,幼淋巴细胞白血病
9 }( }/ l) O# d4 ~3 o1 f5 l6 {4 s# |PLT:platelet,血小板
1 ]9 q5 q8 z9 q; _* r- DPLT:primed lymphocyte test,预致敏淋巴细胞试验
! p# }$ V) Z& l' |PMN:polymorphonuclear leukocyte,多形核白细胞+ S) Z$ q2 l/ z* X9 U- Y
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
" v6 R# `3 L1 K, i/ f& G, u7 n* OPNRE:p53 negative response element,p53阴性反应元件
' q" B' q$ p2 z: j7 q0 C" i' VPOD:PML oncogenic domain,PML癌基因结构域
% u u' I4 p' }2 j {% I/ x0 ePolycythemia:红细胞增多症
, ~: B1 ?, |9 A: cPositive selection:阳性选择: t V7 ]0 C/ f6 l m/ \
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞; r" N, T! K* K* [# Z
Preparative regimen:预处理方案
4 a8 M* m4 i) k7 hProgenitor:前体,祖先3 Z/ u& ~6 p* l/ L. t
Prognosis:预后
& u8 z L* `+ |9 ?Prophylactic:adj.预防的;n. 预防性,预防药
: b/ Q, k& N9 E0 r; I# m dProphylaxis:预防法,预防
. a! N7 ?( ~& Q: xProtocol:草案,协议,治疗方案 $ Y" e* i, S3 T3 x- z' F5 E
Proto-onc: proto-oncogene,原癌基因
# G% `/ V R# _; y, ?PSS:posterior superior spine,髂后上棘
; k: v& Q* z) [; I/ M- ZPT:prothrombin time,凝血酶原时间( j. U4 ~- J( h
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤
- L5 [: d5 N- s- u3 @8 [ l( QPTH:post-transfusion hepatitis, 输血后肝炎0 V3 x6 e8 i0 g e: J* T$ o
Pulmonary:肺的
/ {4 d1 X" i1 yPurging:净化3 g2 {# }! ^- d# v% ?# s' |! q
Purity:纯度2 y& j; L/ t& I- N
PV:polycythemia vera,真性红细胞增多症9 N0 } ?4 u& D9 L9 }
Quality of Life (QOL):生活质量
, ]" O2 N* @7 C/ J1 s( C+ tRA:refractory anemia,难治性贫血 ( E/ ^+ I0 m: B: q: s8 P/ Y5 l
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型9 a0 }9 Z' } G- ]3 N; K9 f
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型
* a7 X% O+ A( A/ ~7 n2 KRAR:retinoic acid receptor,维甲酸受体- a& Z6 d9 N: x) e2 S& q9 @2 n
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多" Z/ K. o C0 v) l; Y4 l$ n
RAS:retinoic acid syndrome,维甲酸综合征
, w' Z5 @* W4 N" C7 q$ t$ I& GRB:retinoblastoma,视网膜母细胞瘤
5 K0 n) Q9 Z, {4 e! URBC: red blood cell,红细胞 / p( e/ [# I' m+ W. y, K, w
Reagent:试剂
* N) b. Z6 h: [4 W3 @% F& C) ARecipient:受者
5 X7 I$ `) B, j6 J; IRejection:排斥' J. C2 |9 r8 ?5 d6 [" ?( n
Relapse:复发
" T% A# d5 N' @8 J) G" T8 BRemission:缓解 + G& t3 X. W5 \/ C d% [
Renal:肾脏的,肾的
w" }* n. _9 j: DRFS:replase free survival,无复发生存
( F. N9 T1 f1 RRPC:radiation protective competence, 辐射保护能力& @0 T3 d) |& ~* V
Regimen-related toxicity (RRT):预处理相关毒性
" u, q- D( p6 y( \+ C+ }RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
" N; w) Q- b8 N! B1 f, T- kSBB:sudan black B,苏丹黑B
' T; t# |( \/ Q# \SCE:sister chromatial exchange,姐妹染色单体交换
' k* n! z3 A" }3 Z8 C* {4 VSCF:stem cell factor,干细胞因子
+ X3 A, C2 L) _SCid:severe combined immunodeficiency disease,重症联合免疫缺陷* v1 L2 i) C0 q- d' i' Q/ v0 K
SCL:stem cell leukemia,干细胞白血病
" _; B+ ?& Y9 O! [4 rSE:specific estarase,特异性酯酶: S# t. r) B& D6 ^$ ~
Selectin:选择素4 ] q9 f L) p9 b
Sense primer:同义引物
" o8 s7 _: h+ p4 t; k. e% k& VSeparation:(细胞)分选
" M( F0 p9 _. \Sepsis:脓血病,败血病 3 v( d1 e0 j7 Y1 E. h6 p- ^
Sequencing测序
& K* m; x& k) V0 o9 K; c- KSF:serum ferritin,血清铁蛋白1 u/ ?. O/ Z _
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大
+ B8 {8 i& v& G5 g* \SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法) e! Z* G* X1 e
SLE:systemic lupus erythematosus,系统性红斑狼疮8 D2 Y1 f1 U8 @, O0 j: l& t
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
* ^2 _" Q& `( y X9 S6 TSolid tumor:实体瘤
* _& z* ~6 {, O9 T8 C7 ?+ _ [, sSR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
- h% O% f- ?+ R# O; |. {" v, W. SSRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞
% C9 z; O& H# w' xSS:Sezary syndrome,Sezary综合征
6 z7 p4 ]2 `9 w% mStem cell:干细胞
% B% n) W! l6 q: NSTNI:subtotal nodal irradiation,次全淋巴结照射 & n3 O& e# Q: G! T$ f5 d
Stomatitis:口炎 - ]* X4 p+ {& O8 R
Subclavian catheter:锁骨下导管
" ~! |; n4 z3 E; e& TSupernatant:上清5 ^6 `- b7 u9 W2 d! S+ k8 x0 X- E2 `5 D
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植
, W8 l$ |' n: k9 H4 rSyngeneic:同基因的
! w; W, {3 l+ @" \4 K0 l. H' BTAM:tumor associated macrophage,肿瘤相关巨噬细胞( f8 e; q. C& n" i+ M1 K
t-AML:treatment associated AML,治疗相关的急性髓性白血病
. a4 ~" P% d% J" X8 e( yTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
: A$ o* ]6 z+ PTAA:tumor associated antigen,肿瘤相关抗原, ]. ], f9 U6 i" R- r! x/ e% |
TBGP:total blood granulocyte pool,总血液粒细胞池# k* @* S8 a1 l+ p1 _
TBI:total body irradiation,全身照射
9 u& a' A' o7 R; c& `# zTc:time of cell cycle, 细胞周期时间
" h$ M% e" m3 }3 _TCD:T cell depletion, T细胞去除
! w) Y( N+ |: n5 w XTCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤
7 H r/ @- k* K- y fTCR:T cell receptor,T细胞受体1 X3 v: H3 [7 t! I8 g6 |! j! P
TCS:tumor cell survival,肿瘤细胞成活
$ k1 G$ {4 a" c3 n% LTEN:total enteral nutrition,完全胃肠内营养/ Q* K2 b e/ ]9 k- X
TF:tissue factor,组织因子% y) W# \1 K8 O( f2 J* K. @
TF:thymic factor,胸腺因子2 Q2 O6 K: n5 j3 N
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物 V% N4 D. Y; M7 V( y2 \% _. R
TGF:therapeutic gain factor,治疗获得系数; c5 M' t7 P+ V' Q! x! e
TGF-β:transforming growth factor-β,转化生长因子β
: A' K# y( F' K/ H+ KThrombocyte:血小板 " [( b! K! D$ L& a
Thrombocytopenia:血小板减少症9 Q) C. [! b( J! ^* m/ P( c5 h
TIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞/ z8 Y. {3 \4 E1 L- t3 d" U6 g3 D" w0 l
TL:testis leukemia睾丸白血病
4 S& W9 r2 K" m, M1 t fTLI:total Lymphoid irradiation,全淋巴照射
- {8 p: z7 u1 k0 J- [1 ^' zThrombotic microangiopathy (TMA):血栓性微血管病, s% I) t/ x+ P9 M! B3 Y
TNF:tumor necrosis factor,肿瘤坏死因子; W* Q2 N3 ?4 k9 b$ g) Q
TNI:total nodal irradiation,全淋巴结照射
. m2 }+ x1 O: j7 N* r( s6 @ {TOPO II:topoisomerase II,拓扑易构酶II
0 h) z. y: Y0 S6 X( I% MToxin:毒素 ; d, G: d! g! J0 L3 u. \' [
Tpdt:potential doubling time,倍增时间 ]( U9 Z& E8 l, G9 b
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病$ ?! n8 ^+ m `( k( V
TPN:total parenteral nutrition,全肠道外营养,静脉高营养8 X6 x' A" g4 C. b& Y5 n0 {
TPO:thrombopoietin,促血小板生成素3 I; {! V( g/ q, t- P8 b7 V( R& D3 ^
TPS:treatment planning system,治疗计划系统1 u6 M1 r8 V& y4 n( G! K; s
Translocation:易位
$ t% N1 U" U1 h. z! E' o, ATrauma:创伤
* c0 Z9 S- H& N9 t4 Y7 JTRM:transplantation related mortality,移植相关死亡率) E" s$ ~& D1 V. u0 J
TSC:timed-sequential chemotherapy,时相序贯化疗
9 [- x$ a# _" L' L& Z) uTSPA:triophosphoramide,噻替派
) l' r* s3 [1 V5 H2 Y! V; o4 l! oTTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜
1 N- P, L4 _' QTumor:肿瘤
4 F. ]0 P. t/ i/ T1 [% yTumor burden:肿瘤负荷 : p( q6 m- @. H- S
UCB:umbilical cord blood,脐带血
6 P6 I; y4 T! w8 KUltrasound:超声
3 r3 Q) ]2 l4 Q$ o+ NUmbilical cord:脐带
' \% G1 j, x' }2 t7 @+ ^VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
. m& F2 y) Y, `VGPR:very good partial remission,非常良好的部分缓解
) f( B; _# L; G8 @$ F( pViability:活性
2 X/ x3 t3 {! h/ j8 n! D! L7 }9 \Virus:病毒 8 A: p: k- J4 c! j* o
VOD:veno-occlusive disease,静脉阻塞性疾病 . D I- w$ {7 P9 k5 m, { I' y( B3 k
v-onc: virus oncogene,病毒癌基因% b5 w; k b( I' G" u6 V- ?& l8 S9 h
VPF: vascular permeability factor,血管渗透因子
( c" W: o; j a. g" E/ PVZV:varicella zoster virus,水痘带状疱疹病毒. a/ w' T/ i& ?+ ^+ S4 g
WBC:white blood cell,白细胞 ) f: j5 K j, F
Whole blood:全血
/ l ?7 l/ z2 [0 U$ q; Q5 }& [WT:Wilms tumor,肾母细胞瘤
* n. V9 s) v# l, N; h sXerostomia:口腔干燥症
j7 \, b& z ]4 B: I1 DYield:产量 |
|